ADAMTSL2 binds to fibrillin-1 and the N-terminal binding site encompasses a fibrillin-1 mutation which results in Weill Marchesani Syndrome (WMS) [69]. The gene discussed is FBN1; the disease is Weill-Marchesani syndrome.